The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options for targeted treatment.

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, ...

The risk of some psoriasis-associated pathologies, such as cardiovascular disease, are better recognized than others.

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities ...

Many patients with IBS and other functional GI disorders experience fragmentation of care and incur high costs. Can a virtual multidisciplinary model be the solution?

Residency spots are more competitive than ever. Here, we look at the good and the bad of the specialties that are making waves.

The FDA has approved belzutifan (Welireg, Merck) in combination with pembrolizumab (Keytruda, Merck) or the subcutaneous formulation of pembrolizumab (Keytruda Qlex, Merck) for the adjuvant treatment ...

An anthracycline-free treatment regimen demonstrated safety and efficacy in standard-risk and high-risk patients.

Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications such as ...

The risk for extrahepatic cancers varies among subgroups of steatotic liver disease, with the highest risk seen in patients ...

Intermittent theta-burst stimulation matches the efficacy of standard transcranial magnetic stimulation for depression in ...

Higher levels of Fitbit-recorded physical activity are linked to lower odds of irritable bowel syndrome, whereas greater ...